English
简体中文
Total: £ 56.28
2026-04-29 | Pages: 130 | Tables: 133
The global Medical Nuclide Products market was valued at US$ 11150 million in 2025 and is anticipated to reach US$ 20510 million by 2032, at a CAGR of 9.2% from 2026 to 2032.Medical nuclide products refer to medical preparations or devices containing...
2026-04-29 | Pages: 120 | Tables: 118
The global Seamless Capsule market was valued at US$ 651 million in 2025 and is anticipated to reach US$ 875 million by 2032, at a CAGR of 4.4% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic la...
2026-04-29 | Pages: 132 | Tables: 128
The global Beta Thalassemia Treatment market was valued at US$ 429 million in 2025 and is anticipated to reach US$ 697 million by 2032, at a CAGR of 7.2% from 2026 to 2032.Beta Thalassemia Treatment refers to a comprehensive set of therapeutic approa...
2026-04-29 | Pages: 125 | Tables: 125
The global Drug-Induced Immune Hemolytic Anemia market was valued at US$ 4423 million in 2025 and is anticipated to reach US$ 6295 million by 2032, at a CAGR of 5.3% from 2026 to 2032.Drug-Induced Immune Hemolytic Anemia (DIIHA) is an immune-mediated...
2026-04-28 | Pages: 111 | Tables: 117
The global HIV Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This rep...
2026-04-28 | Pages: 147 | Tables: 140
The global Liposomal Dietary Supplement market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 493 million by 2032, at a CAGR of 10.4% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the globa...
2026-04-24 | Pages: 120 | Tables: 118
The global Cloprostenol Sodium Injection market was valued at US$ 232 million in 2025 and is anticipated to reach US$ 307 million by 2032, at a CAGR of 4.0% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the globa...
2026-04-24 | Pages: 101 | Tables: 100
The global D-Cloprostenol Sodium Injection market was valued at US$ 174 million in 2025 and is anticipated to reach US$ 234 million by 2032, at a CAGR of 4.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glo...
2026-04-24 | Pages: 108 | Tables: 112
The global Procarbazine market was valued at US$ 87.55 million in 2025 and is anticipated to reach US$ 109 million by 2032, at a CAGR of 3.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-04-24 | Pages: 118 | Tables: 119
The global Antipyretic and Analgesic Drugs market was valued at US$ 14820 million in 2025 and is anticipated to reach US$ 17670 million by 2032, at a CAGR of 2.6% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the...
2026-04-24 | Pages: 125 | Tables: 120
The global Astragalus Extract market was valued at US$ 20.77 million in 2025 and is anticipated to reach US$ 26 million by 2032, at a CAGR of 3.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic...
2026-04-22 | Pages: 116 | Tables: 115
The global Oral Cholera Vaccine market was valued at US$ 108 million in 2025 and is anticipated to reach US$ 178 million by 2032, at a CAGR of 7.5% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-04-22 | Pages: 124 | Tables: 140
The global Radiology Information System (RIS) market was valued at US$ 2446 million in 2025 and is anticipated to reach US$ 3736 million by 2032, at a CAGR of 6.3% from 2026 to 2032.Radiology information system is a kind of medical information techno...
2026-04-22 | Pages: 126 | Tables: 126
The global Cellulose Derivative Excipient market was valued at US$ 2050 million in 2025 and is anticipated to reach US$ 4294 million by 2032, at a CAGR of 11.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
2026-04-22 | Pages: 123 | Tables: 121
The global Escitalopram Oxalate API market was valued at US$ 78.03 million in 2025 and is anticipated to reach US$ 124 million by 2032, at a CAGR of 6.9% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global e...
